Lonza Group AG Lonza Group AG

Lonza Group AG

LONN

주식 순위 #449
Lonza Group AG, together with its subsidiaries, operates as a contract... Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biologics services from clinical development, drug substance, and drug product manufacturing; and operates mammalian and drug product platforms. Its Advanced Synthesis segment manufactures antibody-drug conjugates (ADCs) and other bioconjugates, small molecules, and highly potent active pharmaceutical ingredients; and operates small molecules and bioconjugates platforms. The Specialized Modalities segment operates various technologies, such as spanning cell & gene, microbial, bioscience, and mRNA. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.
주가
$763.31
시가총액
$53.31B
변동 (1일)
0.87%
변동 (1년)
8.49%
국가
CH
거래 Lonza Group AG (LONN)

카테고리

Healthcare
Lonza Group AG (LONN)의 P/B 비율
2026 기준 P/B 비율 TTM: 0
Lonza Group AG의 최신 재무 보고서와 주가에 따르면 현재 P/B 비율(TTM)은 0입니다. 2026년 말 기준 P/B 비율은 0였습니다.
Lonza Group AG의 P/B 비율 기록 (2004 ~ 2026)
매년 말 P/B 비율
연도 P/B 비율 변화
2025 4.12 0.78%
2024 4.09 48.44%
2023 2.76 -13.17%
2022 3.17 -45.28%
2021 5.80 -6.60%
2020 6.21 54.07%
2019 4.03 31.99%
2018 3.05 4.80%
2017 2.91 -20.51%
2016 3.67 -1.63%
2015 3.73 46.34%
2014 2.55 32.62%
2013 1.92 76.08%
2012 1.09 -10.31%
2011 1.22 -26.13%
2010 1.65 3.24%
2009 1.59 -44.54%
2008 2.87 -28.32%
2007 4.01 12.01%
2006 3.58 40.08%
2005 2.56 8.33%
2004 2.36 0.00%
유사 기업 또는 경쟁사의 P/B 비율
회사 P/B 비율 P/B 비율 차이 국가
6.251 -
US
13.2547 -
US
4.4521 -
AU
6.3632 -
NL
3.2932 -
BE